% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{VanderAuwera:280784,
author = {Van der Auwera, Sandra and Ameling, Sabine and Wiechert,
Anja and Friedrich, Nele and Nauck, Matthias and Völzke,
Henry and Bröker, Barbara M and Grabe, Hans J and Völker,
Uwe},
title = {{C}irculating mi{RNA}s and inflammatory markers -
{A}ssociations between mi{RNA}s and cytokine levels point to
mi{RNA}-mediated s{CD}40{L} release from platelets.},
journal = {Cytokine},
volume = {194},
issn = {1043-4666},
address = {Oxford [u.a.]},
publisher = {Elsevier},
reportid = {DZNE-2025-00968},
pages = {157012},
year = {2025},
abstract = {MicroRNAs (miRNAs) are gaining increasing attention,
particularly because of their involvement in immune-related
signaling pathways. We investigated the association between
179 plasma-circulating miRNAs (Plasma Focus microRNA PCR
Panel) and 47 cytokines ('MILLIPLEX® panel) in 692
participants of the population-based SHIP-TREND cohort (age
range 21-79) and two additional cohorts to present a
comprehensive map of miRNA-cytokine relations. Multivariate
linear regression models identified Bonferroni-corrected
significant associations between miRNAs and cytokines for
EGF (pro-epidermal growth factor), PDGF-AA, PDGF-AB/BB
(platelet-derived growth factor subunit A and B), VEGF-A
(vascular endothelia growth factor A), and sCD40L (soluble
CD40 ligand) with sCD40L showing the most robust pattern.
These models were adjusted for age, sex, platelet count,
BMI, smoking, and technical parameters. In the follow-up
sample (N = 191, 7 years after initial sampling), we
confirmed that the observed associations were stable over
time and replicated our findings in an independent clinical
cohort (N = 74). Furthermore, the causal mediation results
provide evidence for the involvement of platelet activity in
the regulation of sCD40L mediated by five miRNAs in the
range of 25 $\%-69$ $\%$ of the effect being mediated
(strongest mediation for hsa-miR-223-3p). Our study
highlights a strong and stable miRNA-mediated modulation of
sCD40L, at the stage of platelet activation with potential
subsequent effects on the interaction of immune cells and
haemostasis pointing to a complex regulatory mechanism.
Future research is needed to determine the clinical
relevance of our observations in the context of vascular
thrombosis, immunological disorders, and neurodegeneration.},
keywords = {Humans / CD40 Ligand: blood / CD40 Ligand: metabolism /
Male / Female / Middle Aged / Blood Platelets: metabolism /
Adult / Cytokines: blood / MicroRNAs: blood / MicroRNAs:
genetics / Aged / Biomarkers: blood / Circulating MicroRNA:
blood / Circulating MicroRNA: genetics / Inflammation: blood
/ Young Adult / Cohort Studies / Circulating biomarkers
(Other) / Platelet activation (Other) / SHIP study (Other) /
miRNA mediated sCD40L release (Other) / miRNA-cytokine
association (Other) / CD40 Ligand (NLM Chemicals) /
Cytokines (NLM Chemicals) / MicroRNAs (NLM Chemicals) /
Biomarkers (NLM Chemicals) / Circulating MicroRNA (NLM
Chemicals)},
cin = {AG Grabe},
ddc = {570},
cid = {I:(DE-2719)5000001},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40803257},
doi = {10.1016/j.cyto.2025.157012},
url = {https://pub.dzne.de/record/280784},
}